Special NoticePosted Sep 21, 2026·Responses due Sep 23, 2026

6505--PET MRI Radiopharmaceuticals, Detroit

Veterans Affairs · 250-NETWORK CONTRACT OFFICE 10 (36C250)

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
325412
Value
Not stated
Solicitation
36C25026Q1039
Set-aside
None stated
PSC
6505
Place
Not stated
Contact
Contract Specialist (james.howard3@va.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 36C25026Q1039 in this department, oldest first.

Early notice
  • Sep 21, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
  • Oct 1, 2026
    Award Notice
    SOFIE Co. DULLES 20166 · $558K
    Open
  • Oct 1, 2026
    Award Notice
    SOFIE Co. DULLES 20166 · $558K
    Open

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

Special Notice Page 4 of 4 INTENT TO SOLE SOURCE The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412 Pharmaceutical Preparati… (show all)

on Manufacturing, and the Business Size Standard is 1,300 employees. The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2026, through September 30, 2027. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients. Product Name UoM Est. Annual Quantity Cu-64 Dotatate (Detectnet) 3-5 mCi Dose 15 F18 PSMA (Pylarify) 8-10 mCi Dose 120 F18 Fluorodeoxyglucose (FDG) 8-10 mCi Dose 200 F18 Neuraceq 8-10 mCi Dose 20 Pylarify (PSMA) Cancellation Fee N/A 22 It is the Government s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25026Q0931 was sent out to prospective vendors, with a reply window of August 18, 2026 through August 20, 2026. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested persons may identify their interests and capability to respond to this requirement no later than 4:00 PM Eastern Time, Wednesday, September 23, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government. Interest/capability statements shall be submitted to James Howard, Contracting Specialist, via e-mail at james.howard3@va.gov. Telephone inquiries will not be accepted.

Who won similar work

6 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325412.

WinnerAwardsValueLast
PROGENICS PHARMACEUTICALS INC2$6.0MMay 8, 2026
RLS (USA) INC.1$5.2MOct 1, 2026
SOFIE Co. DULLES 201661$700KOct 1, 2025
TRILLAMED LLC1$135KNov 27, 2024
REGENTS OF THE UNIVERSITY OF MICHIGAN ANN ARBOR 481091$124KNov 25, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 25 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.